EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
EGFR is frequently constitutively active in glioblastoma (GBM). Here, the authors show that EGFR induces YTHDF2 protein stabilization, which reduces cholesterol homeostasis through an RNA m6A methylation dependent molecular mechanism to promote GBM tumourigenesis.
Saved in:
Main Authors: | Runping Fang, Xin Chen, Sicong Zhang, Hui Shi, Youqiong Ye, Hailing Shi, Zhongyu Zou, Peng Li, Qing Guo, Li Ma, Chuan He, Suyun Huang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/dbb72d0750a2491f8e7c06b1a87b4c5f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway.
by: Yaqiong Yang, et al.
Published: (2021) -
Lamellipodin-RICTOR Signaling Mediates Glioblastoma Cell Invasion and Radiosensitivity Downstream of EGFR
by: Stefanie Moritz, et al.
Published: (2021) -
Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma
by: Leland S. Hu, et al.
Published: (2021) -
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
by: Yulin Shi, et al.
Published: (2019) -
Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina
by: Fahad Farhan, et al.
Published: (2021)